# Clinical Study of Cang Ai Volatile Oil (CAVO) on Mild to Moderate Depression in Children and Adolescents

> **NCT05789186** · EARLY_PHASE1 · UNKNOWN · sponsor: **Chen Qian** · enrollment: 108 (estimated)

## Conditions studied

- Depression

## Interventions

- **DRUG:** CAVO aromatherapy patch at 3% concentration+Fluoxetine hydrochloride mimetic
- **DRUG:** Fluoxetine hydrochloride tablet+CAVO aromatherapy patch at 0.1% concentration
- **DRUG:** Fluoxetine hydrochloride mimetic+CAVO aromatherapy patch at 0.1% concentration

## Key facts

- **NCT ID:** NCT05789186
- **Lead sponsor:** Chen Qian
- **Sponsor class:** OTHER
- **Phase:** EARLY_PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** UNKNOWN
- **Start date:** 2023-05-01
- **Primary completion:** 2023-09-01
- **Final completion:** 2024-01-01
- **Target enrollment:** 108 (ESTIMATED)
- **Last updated:** 2023-03-29


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT05789186

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT05789186, "Clinical Study of Cang Ai Volatile Oil (CAVO) on Mild to Moderate Depression in Children and Adolescents". Retrieved via AI Analytics 2026-07-19 from https://api.ai-analytics.org/clinical/NCT05789186. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*